Latest debt-to-equity ratio
Monopar Therapeutics Debt-to-equity ratio
Direct answer
Monopar Therapeutics's debt-to-equity ratio is 0.16%.
The verified market snapshot reports 0.16%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 27, 2026.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.16%
Explore related company data
View Monopar Therapeutics's market capitalizationView Monopar Therapeutics's price-to-book ratioView Monopar Therapeutics's return on equityView Monopar Therapeutics's 52-week price rangeView Monopar Therapeutics's profit marginView all Monopar Therapeutics key metricsReturn to Monopar Therapeutics profile